Agilent Technologies, Inc.
HealthcareNYSE:A · New York Stock Exchange
-$0.05 today
Vol 0.56M · Avg 2.22M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
19.3%
avg 17.0%
ROIC
12.6%
avg 10.6%
ROA
10.2%
avg 8.9%
Analysis
ROE is currently the strongest return metric at 19.3% versus its period average of 17.0%. 3 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Padraig McDonnell | Chief Executive Officer, President & Director | $2.64M | — | 54 | $65,842.00 | 0.02% |
Simon May | Senior VP and President of Life Sciences & Diagnostics Markets Group | $1.63M | — | 53 | $14,015.49 | <0.01% |
Michael Buckner | Senior Vice President, Chief Legal Officer, & Secretary | $1.18M | — | — | $8,887.00 | <0.01% |
Bret DiMarco | Senior VP & Secretary | $1.18M | — | 58 | $12,203.06 | <0.01% |
Angelica Riemann | Senior VP & President of Agilent CrossLab Group | $1.12M | — | 55 | $26,535.14 | <0.01% |
Rodney Gonsalves | Principal Accounting Officer, Vice President & Corporate Controller | $832,080.00 | — | 60 | $31,845.69 | 0.01% |
Frederick Schwarz | Senior VP, Chief Strategy & Corporate Development Officer | — | — | — | — | — |
Yvonne Mackie | MD of UK & Ireland Operations and Vice President of Human Resources - Europe | — | — | — | — | — |
Meghan A. Henson | Senior Vice President & Chief Human Resources Officer | — | — | 56 | $6,890.00 | <0.01% |
Adam S. Elinoff | Senior Vice President, Chief Financial Officer & Principal Financial Officer | — | — | 48 | $11,726.00 | <0.01% |
August Specht | Senior Vice President & Chief Technology Officer | — | — | — | — | — |
Tejas Rajeev Savant | Vice President of Investor Relations | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
0
$0.00
Sells
9
$3.73M
Net Sentiment
$3.73M
Net selling
Most Active
MCDONNELL PADRAIG
5 transactions
Analysis
Insiders reported 0 buys worth $0.00 and 9 sells worth $3.73M over the last 12 months. That adds up to net selling of $3.73M. MCDONNELL PADRAIG was the most active insider with 5 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | -28.4% | +14.2% (15yr)2 analysts |
| Revenue | N/A | N/A | -16.2% | +5.8% (15yr)9 analysts |
| Net Income | N/A | N/A | -29.7% | +13.0% (15yr)9 analysts |
| EBIT | N/A | N/A | -22.4% | +9.9% (15yr)9 analysts |
Analysis
Recent growth has been strongest in Revenue at -16.2% over three years. Forward estimates point to EPS at +14.2% (15yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Becton, Dickinson and Company
NYSE:BDX
$52.80B
Cardinal Health, Inc.
NYSE:CAH
$52.28B
Edwards Lifesciences Corporation
NYSE:EW
$48.80B
Haleon plc
NYSE:HLN
$40.32B
Alcon Inc.
NYSE:ALC
$32.49B
IQVIA Holdings Inc.
NYSE:IQV
$29.87B
ResMed Inc.
NYSE:RMD
$28.03B
Waters Corporation
NYSE:WAT
$23.20B
Mettler-Toledo International Inc.
NYSE:MTD
$22.83B
Insmed Incorporated
NASDAQ:INSM
$21.19B
Who manages A?
Agilent Technologies, Inc. (A) lists 12 active executives. The top listed executive is Frederick Schwarz, Senior VP, Chief Strategy & Corporate Development Officer.
Are A insiders buying or selling?
Recent insider activity shows net buying of $21.76M.
Explore More
Continue the stock analysis
Jump to another research area for this company.